PARIS, Aug. 29 /PRNewswire-FirstCall/ — Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has submitted a non-binding proposal to acquire Genzyme (Nasdaq: GENZ) in an all-cash transaction valued at approximately$18.5 billion.
Under the terms of the proposed acquisition, Genzyme shareholders would receive $69 per Genzyme share in cash, representing a 38% premium… Continue reading »
BOSTON – Stryker Biotech, a Hopkinton-based medical device company, will pay $1.35 million to the Commonwealth to resolve allegations that it marketed certain orthopedic products for uses that had not been reviewed and approved by the U.S. Food & Drug Administration (FDA) and misled health care providers about the appropriate uses of its products, Attorney… Continue reading »
Langhorne, PA and Jackson, MS – August 26, 2010 . . . . Xylos Corporation (“Xylos”), a leader in biocellulose technology for medical applications, and the University of Mississippi Medical Center (“UMMC”), a leading orthopaedic and level one trauma center, announced today the first human implantation of Securian® Tissue Reinforcement Matrix in a clinical trial for… Continue reading »
DENVER, Aug. 9 /PRNewswire/ – Regenerative Sciences, Inc., a Colorado medical practice that specializes in the use of a person’s own stem cells to help patients avoid more invasive orthopedic surgery, announced today that the US Food and Drug Administration (FDA) is seeking to enjoin the clinic physicians from practicing medicine using patients’ own stem cells. The… Continue reading »
ALACHUA, Fla.–(BUSINESS WIRE)–RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, in response to inquiries regarding Medtronic’s announced acquisition of Osteotech stated today that the relationship between Medtronic and RTI Biologics continues to be strong, with no changes near-term.
“Both companies have taken several steps over… Continue reading »
SAN DIEGO, Aug 12, 2010 (BUSINESS WIRE) — Cytori Therapeutics (CYTX 4.69, +0.13, +2.88%) has received U.S. Patent No. 7,771,716 (the ’716 patent) for Celution(R) System based methods of treating musculoskeletal disorders such as spinal disc disease. The ’716 patent covers the therapeutic use of adipose-derived stem and regenerative cells (ADRCs) for promoting repair and… Continue reading »
NuOrtho Surgical, Inc. today announces that the findings of two separate studies discussing early surgical intervention for the articular cartilage damage of osteoarthritis.
The studies demonstrate that damaged cartilage retains viable cartilage cells at stages of the degeneration process from normal to surface fibrillation. The studies also confirm many previous studies that current treatments… Continue reading »
Cytori Therapeutics, a developer of medical products and devices, has received USpatent for Celution system based methods of treating musculoskeletal disorders such as spinal disc disease.
The patent covers the therapeutic use of adipose-derived stem and regenerative cells for promoting repair and regeneration of the spinal disc and formation… Continue reading »
FRANKLIN, Tenn.–(BUSINESS WIRE)–BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate activities at the Canaccord Genuity 30th Annual Global Growth Conference on Thursday, August 12 at 10:30 a.m. Eastern Time. The presentation will be held in the Toronto Room at The InterContinental… Continue reading »
Scientist Paul Wooley has regrown a section of bone in a mammal’s leg, a breakthrough he and collaborators say will revolutionize bone medicine worldwide. It will dramatically improve treatment for wounded soldiers and many of the tens of thousands of people seriously injured in traffic accidents every year, he said; it could make many future… Continue reading »
EATONTOWN, N.J., Aug. 9 /PRNewswire-FirstCall/ — Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, disclosed today that its Board of Directors engaged Deutsche Bank Securities Inc. in 2009 as its exclusive financial advisor to assist in the identification and evaluation of a range of strategic alternatives focused… Continue reading »
BELGRADE, Mont., Aug. 5 /PRNewswire-FirstCall/ — Bacterin International Holdings, Inc. (“Bacterin” or the “Company”) (OTC Bulletin Board: BIHI), a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of… Continue reading »
Minneapolis – July 27, 2010 – The U.S. Food and Drug Administration (FDA) Orthopaedic and Rehabilitation Devices Panel today voted 9 for and 4 against (1 abstention) on safety and 10 for and 3 against (1 abstention) on effectiveness, that data including results from a large, prospective randomized clinical trial demonstrated the safety and effectiveness… Continue reading »
NEW YORK & PETACH TIKVAH, Israel–(BUSINESS WIRE)–BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, today announced that it has retained MD Becker Partners LLC, a boutique management and strategy consulting firm focusing on both public and private companies in the life sciences industry.
As a… Continue reading »
ALACHUA, Fla.–(BUSINESS WIRE)–RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, announced today that Dean H. Bergy, 50, of Stryker Corporation has joined the company’s board of directors. He will be up for re-election in 2012.
“We are very pleased to have Dean join our… Continue reading »